{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:11:09Z","timestamp":1768453869399,"version":"3.49.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral Biosciences"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.job.2021.04.002","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T01:27:19Z","timestamp":1618795639000},"page":"104-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sclerostin and its role as a bone modifying agent in periodontal disease"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3554-293X","authenticated-orcid":false,"given":"Nisha","family":"Ashifa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1093-0060","authenticated-orcid":false,"given":"Krishnan","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajasekar","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sivapragasam","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.job.2021.04.002_bib1","article-title":"Identification of gingival crevicular fluid sampling, analytical methods, and oral biomarkers for the diagnosis and monitoring of periodontal diseases: a systematic review","volume":"2016","author":"Majeed","year":"2016","journal-title":"Dis Markers"},{"key":"10.1016\/j.job.2021.04.002_bib2","first-page":"126","article-title":"Oral fluid-based biomarkers in periodontal disease - part 2. Gingival crevicular fluid","volume":"6","author":"AlRowis","year":"2014","journal-title":"J\u00a0Int Oral Heal JIOH"},{"key":"10.1016\/j.job.2021.04.002_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0765.2005.00814.x","article-title":"Inflammatory bone destruction and osteoimmunology","volume":"40","author":"Takayanagi","year":"2005","journal-title":"J\u00a0Periodontal Res"},{"key":"10.1016\/j.job.2021.04.002_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145169","article-title":"Osteocyte-related cytokines regulate osteoclast formation and bone resorption","volume":"21","author":"Kitaura","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.job.2021.04.002_bib5","first-page":"271","article-title":"Effect of sclerostin removal in\u00a0vivo on experimental periodontitis in mice","volume":"58","author":"Yang","year":"2016","journal-title":"J\u00a0Oral Sci"},{"key":"10.1016\/j.job.2021.04.002_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025900","article-title":"Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway","volume":"6","author":"Wijenayaka","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.job.2021.04.002_bib7","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.1074\/jbc.M807994200","article-title":"Characterization of the structural features and interactions of sclerostin. Molecular insight into a key regulator of Wnt-mediated bone formation","volume":"284","author":"Veverka","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.job.2021.04.002_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00223-010-9372-1","article-title":"Sclerostin: current knowledge and future perspectives","volume":"87","author":"Moester","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.job.2021.04.002_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bone.2016.10.012","article-title":"Sclerostin measurement in human disease: validity and current limitations","volume":"96","author":"Costa","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.job.2021.04.002_bib10","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.bbrc.2014.03.079","article-title":"New insights into the location and form of sclerostin","volume":"446","author":"Hernandez","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.job.2021.04.002_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2106\/JBJS.G.01183","article-title":"Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling","volume":"90","author":"Ten Dijke","year":"2008","journal-title":"J\u00a0Bone Jt Surg - Ser A"},{"key":"10.1016\/j.job.2021.04.002_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1086\/301721","article-title":"Van Buchem disease (Hyperostosis corticalis generalisata) maps to chromosome 17q12-q21","volume":"62","author":"Van Hul","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.job.2021.04.002_bib13","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/302416","article-title":"Localization of the gene for sclerosteosis to the van Buchem disease- gene region on chromosome 17q12-q21","volume":"64","author":"Balemans","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.job.2021.04.002_bib14","doi-asserted-by":"crossref","first-page":"R167","DOI":"10.1530\/JME-18-0176","article-title":"Novel actions of sclerostin on bone","volume":"62","author":"Holdsworth","year":"2019","journal-title":"J\u00a0Mol Endocrinol"},{"key":"10.1016\/j.job.2021.04.002_bib15","series-title":"Hum. Mol. Genet.-2001-Balemans-537-43.pdf","first-page":"537","volume":"vol. 10","author":"Balemans","year":"2001"},{"key":"10.1016\/j.job.2021.04.002_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11914-014-0188-1","article-title":"Developments in sclerostin biology: regulation of gene expression, mechanisms of action, and physiological functions","volume":"12","author":"Weivoda","year":"2014","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.job.2021.04.002_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","article-title":"Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease","volume":"39","author":"Balemans","year":"2002","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.job.2021.04.002_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","article-title":"Role and mechanism of action of sclerostin in bone","volume":"96","author":"Delgado-Calle","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.job.2021.04.002_bib19","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1210\/en.2003-1492","article-title":"Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis","volume":"145","author":"Ohyama","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.job.2021.04.002_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/0022034509338340","article-title":"Sclerostin in mineralized matrices and van buchem disease","volume":"88","author":"Van Bezooijen","year":"2009","journal-title":"J\u00a0Dent Res"},{"key":"10.1016\/j.job.2021.04.002_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11914-011-0089-5","article-title":"Sclerostin: therapeutic horizons based upon its actions","volume":"10","author":"Costa","year":"2012","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.job.2021.04.002_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bone.2016.11.024","article-title":"Sclerostin expression and functions beyond the osteocyte","volume":"96","author":"Weivoda","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.job.2021.04.002_bib23","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/dvdy.21054","article-title":"SOST expression is restricted to the great arteries during embryonic and neonatal cardiovascular development","volume":"236","author":"Van Bezooijen","year":"2007","journal-title":"Dev Dynam"},{"key":"10.1016\/j.job.2021.04.002_bib24","article-title":"The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells","volume":"6","author":"Zhu","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.job.2021.04.002_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aac4351","article-title":"Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction","volume":"8","author":"Wehmeyer","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.job.2021.04.002_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-015-0674-6","article-title":"DNA methylation regulates sclerostin (SOST) expression in osteoarthritic chondrocytes by bone morphogenetic protein 2 (BMP-2) induced changes in Smads binding affinity to the CpG region of SOST promoter","volume":"17","author":"Papathanasiou","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.job.2021.04.002_bib27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/art.37802","article-title":"Sclerostin is expressed in articular cartilage but loss or inhibition does not affect cartilage remodeling during aging or following mechanical injury","volume":"65","author":"Roudier","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.job.2021.04.002_bib28","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/ijc.27342","article-title":"Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy","volume":"131","author":"Terpos","year":"2012","journal-title":"Int J Canc"},{"key":"10.1016\/j.job.2021.04.002_bib29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1759720X13510479","article-title":"Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseases","volume":"6","author":"Lewiecki","year":"2014","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.job.2021.04.002_bib30","first-page":"3231","article-title":"Distinct roles for Hedgehog and canonical Wnt signaling in specification","volume":"3244","author":"Rodda","year":"2006","journal-title":"differentiation and maintenance of osteoblast progenitors"},{"key":"10.1016\/j.job.2021.04.002_bib31","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.devcel.2005.02.013","article-title":"Canonical Wnt\/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes","volume":"8","author":"Hill","year":"2005","journal-title":"Dev Cell"},{"key":"10.1016\/j.job.2021.04.002_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1242\/dev.01564","article-title":"Sequential roles of Hedgehog and Wnt signaling in osteoblast development","volume":"132","author":"Hu","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.job.2021.04.002_bib33","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.devcel.2005.03.016","article-title":"Wnt\/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis","volume":"8","author":"Day","year":"2005","journal-title":"Dev Cell"},{"key":"10.1016\/j.job.2021.04.002_bib34","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","article-title":"Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation","volume":"8","author":"Glass","year":"2005","journal-title":"Dev Cell"},{"key":"10.1016\/j.job.2021.04.002_bib35","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1128\/MCB.01428-09","article-title":"Osteocyte Wnt\/beta-catenin signaling is required for normal bone homeostasis","volume":"30","author":"Kramer","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.job.2021.04.002_bib36","doi-asserted-by":"crossref","first-page":"26770","DOI":"10.1074\/jbc.M504308200","article-title":"SOST is a ligand for LRP5\/LRP6 and a Wnt signaling inhibitor","volume":"280","author":"Sem\u00ebnov","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.job.2021.04.002_bib37","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.job.2021.04.002_bib38","doi-asserted-by":"crossref","first-page":"41614","DOI":"10.1074\/jbc.M110.153890","article-title":"Distinct modes of inhibition by Sclerostin on bone morphogenetic protein and Wnt signaling pathways","volume":"285","author":"Krause","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.job.2021.04.002_bib39","first-page":"2","article-title":"Sclerostin: from bench to bedside","author":"Tanaka","year":"2020","journal-title":"J\u00a0Bone Miner Metabol"},{"key":"10.1016\/j.job.2021.04.002_bib40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1210\/er.2002-0023","article-title":"Bone morphogenetic proteins, their antagonists, and the skeleton","volume":"24","author":"Canalis","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.job.2021.04.002_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1359\/jbmr.061002","article-title":"Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation","volume":"22","author":"Van Bezooijen","year":"2007","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.job.2021.04.002_bib42","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20031454","article-title":"Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist","volume":"199","author":"Van Bezooijen","year":"2004","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.job.2021.04.002_bib43","doi-asserted-by":"crossref","first-page":"36293","DOI":"10.1074\/jbc.M400521200","article-title":"Noggin and sclerostin bone morphogenetic protein antagonists form a mutually inhibitory complex","volume":"279","author":"Winkler","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.job.2021.04.002_bib44","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1128\/MCB.05980-11","article-title":"Biphasic and dosage-dependent regulation of osteoclastogenesis by \u2424 -catenin","volume":"31","author":"Wei","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.job.2021.04.002_bib45","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bone.2014.07.031","article-title":"Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats","volume":"67","author":"Stolina","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.job.2021.04.002_bib46","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1074\/jbc.M705092200","article-title":"Mechanical stimulation of bone in\u00a0vivo reduces osteocyte expression of Sost\/sclerostin","volume":"283","author":"Robling","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.job.2021.04.002_bib47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bone.2011.10.025","article-title":"Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading","volume":"50","author":"Tu","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.job.2021.04.002_bib48","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1359\/jbmr.090411","article-title":"Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt\/\u03b2-catenin signaling","volume":"24","author":"Lin","year":"2009","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.job.2021.04.002_bib49","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.217","article-title":"Relation of age, gender, and bone mass to circulating sclerostin levels in women and men","volume":"26","author":"M\u00f6dder","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.job.2021.04.002_bib50","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2011-2152","article-title":"Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults","volume":"97","author":"Amrein","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.job.2021.04.002_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2013.10.019","article-title":"Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans","volume":"59","author":"Roforth","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.job.2021.04.002_bib52","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00296-015-3294-1","article-title":"Serum sclerostin is decreased following vitamin D treatment in young vitamin D-deficient female adults","volume":"35","author":"Cidem","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.job.2021.04.002_bib53","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1055\/s-0035-1559790","article-title":"Effect of vitamin D treatment on serum sclerostin level","volume":"125","author":"Aclbucu","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.job.2021.04.002_bib54","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/EJE-13-0862","article-title":"Effect of supplemental vitamin D and calcium on serum sclerostin levels","volume":"170","author":"Dawson-Hughes","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.job.2021.04.002_bib55","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.mce.2015.06.021","article-title":"1\u03b1,25-dihydroxyvitamin D3 stimulates human SOST gene expression and sclerostin secretion","volume":"413","author":"Wijenayaka","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.job.2021.04.002_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0017772","article-title":"Prostaglandin E2 signals through PTGER2 to regulate sclerostin expression","volume":"6","author":"Genetos","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.job.2021.04.002_bib57","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bone.2015.03.019","article-title":"In\u00a0vivo mechanical loading rapidly activates \u03b2-catenin signaling in osteocytes through a prostaglandin mediated mechanism","volume":"76","author":"Lara-Castillo","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.job.2021.04.002_bib58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1359\/jbmr.1997.12.1.45","article-title":"Pulsating fluid flow stimulates prostaglandin release and inducible prostaglandin G\/H synthase mRNA expression in primary mouse bone cells","volume":"12","author":"Klein-Nulend","year":"1997","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.job.2021.04.002_bib59","first-page":"358","article-title":"Downregulation of SOST\/sclerostin by PTH: a novel mechanism of hormonal control of bone formation mediated by osteocytes","volume":"6","author":"Bellido","year":"2006","journal-title":"J\u00a0Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.job.2021.04.002_bib60","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","article-title":"SOST is a target gene for PTH in bone","volume":"37","author":"Keller","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.job.2021.04.002_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002942","article-title":"Control of bone mass and remodeling by PTH receptor signaling in osteocytes","volume":"3","author":"O'Brien","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.job.2021.04.002_bib62","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bone.2011.11.016","article-title":"TGF-\u03b2 regulates sclerostin expression via the ECR5 enhancer","volume":"50","author":"Loots","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.job.2021.04.002_bib63","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.23954","article-title":"Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization","volume":"58","author":"Yao","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.job.2021.04.002_bib64","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1530\/EC-19-0104","article-title":"Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans","volume":"8","author":"Thiele","year":"2019","journal-title":"Endocr Connect"},{"key":"10.1016\/j.job.2021.04.002_bib65","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1101\/gr.3437105","article-title":"Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease","volume":"15","author":"Loots","year":"2005","journal-title":"Genome Res"},{"key":"10.1016\/j.job.2021.04.002_bib66","doi-asserted-by":"crossref","first-page":"14092","DOI":"10.1073\/pnas.1207188109","article-title":"Targeted deletion of Sost distal enhancer increases bone formation and bone mass","volume":"109","author":"Collette","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.job.2021.04.002_bib67","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/jbmr.1491","article-title":"DNA methylation contributes to the regulation of sclerostin expression in human osteocytes","volume":"27","author":"Delgado-Calle","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.job.2021.04.002_bib68","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3892\/etm.2016.3124","article-title":"Sclerostin is essential for alveolar bone loss in occlusal hypofunction","volume":"11","author":"Xu","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.job.2021.04.002_bib69","doi-asserted-by":"crossref","first-page":"e12369","DOI":"10.1111\/jicd.12369","article-title":"Differential expression of periostin, sclerostin, receptor activator of nuclear factor-\u03baB, and receptor activator of nuclear factor-\u03baB ligand genes in severe chronic periodontitis","volume":"10","author":"Sankardas","year":"2019","journal-title":"J\u00a0Investig Clin Dent"},{"key":"10.1016\/j.job.2021.04.002_bib70","first-page":"e370","article-title":"Receptor activator of nuclear factor-\u03baB ligand and sclerostin expression in osteocytes of alveolar bone in rats with ligature-induced periodontitis","volume":"85","author":"Kim","year":"2014","journal-title":"J\u00a0Periodontol"},{"key":"10.1016\/j.job.2021.04.002_bib71","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/jre.12659","article-title":"Sclerostin and WNT-5a gingival protein levels in chronic periodontitis and health","volume":"54","author":"Chatzopoulos","year":"2019","journal-title":"J\u00a0Periodontal Res"},{"key":"10.1016\/j.job.2021.04.002_bib72","first-page":"1396","article-title":"Gingival crevicular fluid levels of sclerostin, osteoprotegerin, and receptor activator of nuclear factor-\u03baB ligand in periodontitis","volume":"86","author":"Balli","year":"2015","journal-title":"J\u00a0Periodontol"},{"key":"10.1016\/j.job.2021.04.002_bib73","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5125\/jkaoms.2018.44.6.289","article-title":"Gingival crevicular fluid levels of sclerostin in chronic periodontitis and healthy subjects","volume":"44","author":"Esfahrood","year":"2018","journal-title":"J\u00a0Korean Assoc Oral Maxillofac Surg"},{"key":"10.1016\/j.job.2021.04.002_bib74","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/jcpe.12245","article-title":"Involvement of the Wnt-\u03b2-catenin signalling antagonists, sclerostin and dickkopf-related protein 1, in chronic periodontitis","volume":"41","author":"Napimoga","year":"2014","journal-title":"J\u00a0Clin Periodontol"},{"key":"10.1016\/j.job.2021.04.002_bib75","first-page":"21268","article-title":"Evaluation of bone metabolism marker Sclerostin and its correlation with clinical parametes in chronic periodontitis patients: an observational study","volume":"9","author":"Dheeraj","year":"2020","journal-title":"Int J Curr Adv Res"},{"key":"10.1016\/j.job.2021.04.002_bib76","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cyto.2018.10.021","article-title":"Evaluation of gingival crevicular fluid and peri-implant crevicular fluid levels of sclerostin, TWEAK, RANKL and OPG","volume":"113","author":"Yakar","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.job.2021.04.002_bib77","first-page":"1566","article-title":"Estimation of bone loss biomarkers as a diagnostic tool for peri-implantitis","volume":"85","author":"Rakic","year":"2014","journal-title":"J\u00a0Periodontol"},{"key":"10.1016\/j.job.2021.04.002_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/s41368-019-0064-z","article-title":"The cytokine network involved in the host immune response to periodontitis","volume":"11","author":"Pan","year":"2019","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.job.2021.04.002_bib79","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1600-0765.2012.01500.x","article-title":"Comparison of CCL28, interleukin-8, interleukin-1\u03b2 and tumor necrosis factor-alpha in subjects with gingivitis, chronic periodontitis and generalized aggressive periodontitis","volume":"48","author":"Ertugrul","year":"2013","journal-title":"J\u00a0Periodontal Res"},{"key":"10.1016\/j.job.2021.04.002_bib80","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.archoralbio.2014.04.007","article-title":"Amount of interleukin-1\u03b2 and interleukin-1 receptor antagonist in periodontitis and healthy patients","volume":"59","author":"Gilowski","year":"2014","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.job.2021.04.002_bib81","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s10266-020-00502-2","article-title":"Impact of non-surgical periodontal treatment on salivary expression of cytokines related to bone metabolism","volume":"108","author":"Beiler","year":"2020","journal-title":"Odontology"},{"key":"10.1016\/j.job.2021.04.002_bib82","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1600-051X.2007.01061.x","article-title":"Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio","volume":"34","author":"Bostanci","year":"2007","journal-title":"J\u00a0Clin Periodontol"},{"key":"10.1016\/j.job.2021.04.002_bib83","article-title":"Assessment of salivary levels of RANKL and OPG in aggressive versus chronic periodontitis","volume":"2019","author":"Teodorescu","year":"2019","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.job.2021.04.002_bib84","first-page":"1586","article-title":"Levels of cytokine receptor activator of nuclear factor kappaB ligand in gingival crevicular fluid in untreated chronic periodontitis patients","volume":"75","author":"Vernal","year":"2004","journal-title":"J\u00a0Periodontol"},{"key":"10.1016\/j.job.2021.04.002_bib85","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1136\/ard.2010.132852","article-title":"Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression","volume":"69","author":"Heiland","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.job.2021.04.002_bib86","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/782382","article-title":"The role of IL-1\u03b2 in the bone loss during rheumatic diseases","volume":"2015","author":"Ruscitti","year":"2015","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.job.2021.04.002_bib87","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/jcp.24487","article-title":"TNF-\u03b1 upregulates sclerostin expression in obese mice fed a high-fat diet","volume":"229","author":"Baek","year":"2014","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.job.2021.04.002_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2019.00159","article-title":"Sclerostin antibody mitigates estrogen deficiency-inducted marrow lipid accumulation assessed by proton MR spectroscopy","volume":"10","author":"Li","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.job.2021.04.002_bib89","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.job.2021.04.002_bib90","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bone.2015.04.002","article-title":"Sclerostin antibody treatment causes greater alveolar crest height and bone mass in an ovariectomized rat model of localized periodontitis","volume":"76","author":"Chen","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.job.2021.04.002_bib91","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.job.2021.04.002_bib92","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.job.2021.04.002_bib93","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.job.2021.04.002_bib94","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jbmr.3622","article-title":"One year of romosozumab followed by two years of denosumab maintains fracture risk reductions: results of the FRAME extension study","volume":"34","author":"Lewiecki","year":"2019","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.job.2021.04.002_bib95","doi-asserted-by":"crossref","first-page":"115121","DOI":"10.1016\/j.bone.2019.115121","article-title":"Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: systematic review and meta- analysis","volume":"130","author":"Lv","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.job.2021.04.002_bib96","doi-asserted-by":"crossref","first-page":"476","DOI":"10.14310\/horm.2002.1552","article-title":"The sclerostin story: from human genetics to the development of novel anabolic treatment for osteoporosis","volume":"13","author":"Yavropoulou","year":"2014","journal-title":"Hormones (Basel)"},{"key":"10.1016\/j.job.2021.04.002_bib97","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1002\/jbmr.1984","article-title":"Sclerostin antibody stimulates bone regeneration after experimental periodontitis","volume":"28","author":"Taut","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.job.2021.04.002_bib98","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2106\/JBJS.N.00654","article-title":"Sclerostin antibody treatment improves implant fixation in a model of severe osteoporosis","volume":"97","author":"Virdi","year":"2015","journal-title":"J\u00a0Bone Jt Surg - Am"},{"key":"10.1016\/j.job.2021.04.002_bib99","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1089\/ten.tea.2018.0013","article-title":"Sclerostin-neutralizing antibody enhances bone regeneration around oral implants","volume":"24","author":"Yu","year":"2018","journal-title":"Tissue Eng"},{"key":"10.1016\/j.job.2021.04.002_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-73026-y","article-title":"Sclerostin antibody stimulates periodontal regeneration in large alveolar bone defects","volume":"10","author":"Yao","year":"2020","journal-title":"Sci Rep"}],"container-title":["Journal of Oral Biosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1349007921000542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1349007921000542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:06:28Z","timestamp":1761163588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1349007921000542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1349007921000542"],"URL":"https:\/\/doi.org\/10.1016\/j.job.2021.04.002","relation":{},"ISSN":["1349-0079"],"issn-type":[{"value":"1349-0079","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sclerostin and its role as a bone modifying agent in periodontal disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral Biosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.job.2021.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Association for Oral Biology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}